.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Johnson and Johnson
Novartis
Fuji
Federal Trade Commission
Farmers Insurance
Chinese Patent Office
Harvard Business School
Medtronic
Dow

Generated: July 22, 2017

DrugPatentWatch Database Preview

OMEPRAZOLE MAGNESIUM Drug Profile

« Back to Dashboard

What is the patent landscape for Omeprazole Magnesium, and what generic Omeprazole Magnesium alternatives are available?

Omeprazole Magnesium is a drug marketed by Perrigo R And D and Dr Reddys Labs Ltd and is included in two NDAs.

The generic ingredient in OMEPRAZOLE MAGNESIUM is omeprazole magnesium. There are one hundred and twenty-one drug master file entries for this compound. Twenty suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the omeprazole magnesium profile page.

Summary for Tradename: OMEPRAZOLE MAGNESIUM

Patents:0
Applicants:2
NDAs:2
Suppliers / Packagers: see list17
Bulk Api Vendors: see list148
Clinical Trials: see list685
Patent Applications: see list5,301
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:OMEPRAZOLE MAGNESIUM at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Perrigo R And D
OMEPRAZOLE MAGNESIUM
omeprazole magnesium
TABLET, DELAYED RELEASE;ORAL204152-001Jul 30, 2015OTCNoNo► Subscribe► Subscribe
Dr Reddys Labs Ltd
OMEPRAZOLE MAGNESIUM
omeprazole magnesium
CAPSULE, DELAYED RELEASE;ORAL078878-001Jun 5, 2009OTCNoYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Dow
Johnson and Johnson
Novartis
Cipla
Medtronic
UBS
Fuji
Express Scripts
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot